PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for August 24, 2006 Subscribe to this News Feed    
 

On the Horizon: Pheromone Sciences Commercializing the 'Reversal of Diabetes'

Research being conducted at the University of Western Ontario by a world-renown immunologist may help bring about the commercialization of a surgical procedure for patients with Type 1 diabetics.

Sarasota, FL (PRWEB) August 24, 2006 -- Current diabetic research being conducted by Pheromone Sciences (TSX:PHS) may build upon the University of Minnesota’s success in reversing diabetes in monkeys with islet cell transplants derived from the pancreas of pigs. One of the problems with the Minnesota animal experiments were the use of a cocktail of immunosuppression drugs to help the immune systems of monkeys accept the islet cells from pig pancreas.

Dr. David White, chairman of the scientific advisory board for Pheromone Science Corp and Novartis/Stiller Professor of Xenotransplantation at the University of Western Ontario, told StockInterview.com, “When it comes to animal-to human transplants, the amount of immunosuppressive drugs that you have to give to stop this rejection is dangerous to the patient.” White told StockInterview, “We’ve been looking for a way to transplant these islets without having to give these dangerous drugs.”

The world-renown immunologist’s procedure would inject a combination of Sertoli cells and islet cells from pigs into the Type 1 diabetic patient to eliminate the necessity of immunosuppression drugs and to prevent the body’s rejection of the transplanted cells. The use of Sertoli cells would facilitate acceptance of the pig islet cells by the human body’s immune system.” We’re actually in the curious situation that we already have the clinical trials done, and now we’re working on the pre-clinical studies,” Dr. White told StockInterview.

ABOUT STOCKINTERVIEW.COM

For the entire interview with Dr. David White, please visit:
http://www.stockinterview.com/News/08242006/diabetes.html

Stockinterview.com is a rapidly growing online news service, which provides investigative reporting, editorial, analysis and commentary of the nuclear fuel cycle, uranium mining, nuclear power, the environment and the natural resource industry. Over the past three years, the Internet news website has covered the nuclear energy renaissance, the worldwide uranium mining boom and the potential influence of alternative fuel sources on China’s dramatic economic growth.

Contact:
Julie Ickes
Editor, StockInterview.com
Telephone: (941) 929-1640
http://www.stockinterview.com

(SOURCE: StockInterview.com)

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Julie Ickes
STOCKINTERVIEW.COM
941-929-1640
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.